Revaccination With Pneumococcal Conjugate Vaccine - Characterization of the Immune Response After Polysaccharide.

Trial Profile

Revaccination With Pneumococcal Conjugate Vaccine - Characterization of the Immune Response After Polysaccharide.

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Nov 2013

At a glance

  • Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
  • Indications Pneumococcal infections
  • Focus Pharmacodynamics
  • Acronyms REPLAY
  • Sponsors Wyeth
  • Most Recent Events

    • 08 Dec 2010 Actual end date changed from Dec 2009 to Aug 2010 as reported by ClinicalTrials.gov.
    • 05 Mar 2010 Actual number of patients (90) added as reported by ClinicalTrials.gov.
    • 05 Mar 2010 Actual end date (1 Dec 2009) added as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top